Carrier Screening Market is segmented by Product & Service Type (Services and Products),by Type (Expanded Carrier Screening and Targeted Disease Carrier Screening),by Medical Condition Type (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and Others),by Technology Type (Polymerase Chain Reaction and Microarrays),and by Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The U.K., Russia, and Rest of Europe], Asia-Pacific [China, Japan, India, South Korea, and Rest of Asia-Pacific], and Rest of the World [Brazil, Saudi Arabia, Israel, and Others]).
Carrier Screening Market is segmented by Product & Service Type ...
“The Carrier Screening Market was estimated at US$ 1.41 billion in 2021 and is expected to grow at a CAGR of 11.28% during 2022-2028 to reach US$ ~3.81 billion in 2028”.
Carrier screening is a type of genetic testing used to determine the origin of gene abnormalities. This type of test is typically performed during pregnancy and gives important information regarding the woman's reproductive risks as well as the possibility of a genetic condition in the child.
The need for this type of examination has increased to prevent any problems or concerns. It is now possible to discover around 100 illnesses from a single sample using expanded carrier screening. Furthermore, by studying the family medical history, focused carrier screening aids in the identification of any disease. In addition, medical diseases such as pulmonary and hemorrhagic illnesses will experience the greatest rise in the carrier screening market.
Market Drivers
The decrease in the cost of sequencing, the increasing emphasis on early identification and prevention of complex genetic abnormalities, and the increasing maternal age leading to pregnancy problems are projected to fuel the expansion of the carrier screening market. However, major barriers to market growth exist, including regulatory issues in the realm of carrier screening and a lack of high-complexity testing centers. Carrier screening is a hereditary test that determines whether a person possesses a gene that causes certain genetic illnesses.
It is done before or during pregnancy. Carrier screening determines the likelihood of having a kid with a genetic disease. Carrier screening is analyzing blood, saliva, or tissue collected from within the body.
The carrier screening market is a developing one with enormous growth potential. Recent technological developments are aiding the quick adoption of technology. Carrier screening is a set of genetic tests used to determine whether a person is a prospective carrier of genetic illnesses such as cystic fibrosis (CF), Down syndrome, Fragile X syndrome, sickle cell anemia, and spinal muscular atrophy (SMA). Carrier screening tests are widely used by couples planning pregnancy to identify the possibility of transferring genetic abnormalities to the kid.
The earlier a condition is diagnosed, the more likely it will be cured or controlled successfully. Early treatment of the disease may also make it simpler to live with. Early disease detection allows people to plan while they are still able to make vital health and support decisions, as well as financial and legal considerations. Inherited genetic diseases include cystic fibrosis, sickle cell anemia, and Tay-Sachs disease.
Carrier testing for such disorders can advise a couple about their chances of delivering a kid with a genetic problem. The identification of the risk before the onset of symptoms is referred to as predictive/presymptomatic testing. Many genetic diseases are detectable early in pregnancy. As a result, customer demand for safe and effective carrier tests is increasing the market growth.
The incorporation of carrier tests into routine clinical treatment provides the market with a competitive edge. Many studies show that early detection of diseases can fully prevent them or at least reduce their effects. Several countries' healthcare organizations are funding newborn screening to predict disorders such as cancer that may emerge later in life. However, the social and ethical implications of carrier screening, as well as the high prices and reimbursement challenges associated with carrier testing, are limiting the market's expansion.
Several investments/guidelines in the industry have been directed in recent years, which would boost the overall market. Some of them are:
The presence of well-established guidelines regarding carrier screening, the presence of established companies pursuing key business strategies, the decrease in the cost of sequencing, the rising emphasis on early detection and prevention of complex genetic disorders, and the increasing maternal age leading to pregnancy complications, among other factors, have all contributed to the growth of this market. Furthermore, an increased emphasis on carrier screening research, such as targeted carrier screening in spinal muscular atrophy and the growing application of preconception carrier screening, is likely to help the carrier screening market's growth.
Recent Mergers & Acquisitions
The market for carrier screening is highly competitive. The state of the economy and government assistance have a direct impact on the expansion of businesses. Based on their product's quality and market penetration in both the target and growing markets, these companies distinguish their carrier screening driver in the industry.
Furthermore, recent important mergers and acquisitions in the sector have had a big impact on the dynamics of competition. For instance:
In March 2022, BillionToOne received USD 125 million in Series C funding, co-led by Adams Street Partners and existing investor Hummingbird Ventures, with participation from Baillie Gifford, Neotribe Ventures, Norwest Venture Partners, Civilization Ventures, Fifty Years VC, Pacific 8 Ventures, Time BioVentures, and Libertus Capital, among others.
In January 2022, Mitera announced the availability of its at-home reproductive genetic testing products Peaches & Me and 23 Pears in all 50 states. It looks for conditions like Down syndrome.
In June 2021, Grail debuted the Galleri blood test, a revolutionary multi-cancer screening test. The test was designed to check patients who are already at high risk of cancer, such as persons over the age of 50.
In 2018, Invitae Corporation introduced its comprehensive genetic screening equipment.
In 2017, GenPath Women's Health, an OPKO Health company, launched CalriTest, a non-invasive prenatal screening technique. This device will aid in the identification of aberrant chromosomes.
Segments Analysis
By Product & Service Type
The market is segmented into products and services.
By Technology Type
The market is divided into polymerase chain reactions and microarrays.
By Type
The market is divided into expanded carrier screening and targeted disease carrier screening.
By Application Type
The market is further segmented into pulmonary conditions, hematological conditions, neurological conditions, and others.
Regional Analysis
“North America is expected to remain the largest market over the next five years, whereas Asia-Pacific is likely to grow at the fastest rate”.
The market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America has the greatest market share due to increased healthcare infrastructure, rising per capita income, and improved reimbursement policies in the region. The Asia-Pacific area, on the other hand, is expected to develop at the quickest CAGR throughout the forecast period.
Want to know which region offers the best growth opportunities?Register Here
Key Players
The following are the key players in the Carrier Screening Market (arranged alphabetically)
Eurofins Scientific
Fulgenmt Genetics Inc.
Illumina Inc.
Invitae Corporation
Laboratory Corporation of America Holdings
Opko Health
Quest Diagnostics Incorporated
Sema4
The overall competitive landscape has been affected due to key strategies.
Note: The above list does not necessarily include all the top players in the market.
Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
What Deliverables Will You Get in this Report?
Key questions this report answers
Relevant contents in the report
How big is the sales opportunity?
in-depth Analysis of the Carrier Screening Market
How lucrative is the future?
The market forecast and trend data and emerging trends
Which regions offer the best sales opportunities?
Global, regional, and country-level historical data and forecasts
Which are the most attractive market segments?
Market segment analysis and Forecast
Which are the top players and their market positioning?
Porter’s five forces analysis, PEST analysis, Life cycle analysis
What are the factors affecting the market?
Drivers & challenges
Will I get the information on my specific requirement?
10% free customization
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.
We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.
Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Detailed profiling of additional market players (up to three players)
SWOT analysis of key players (up to three players)
Competitive Benchmarking
Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research:
Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.
LOADING
LOADING
×
Please enter your contact details. It will allow our analysts to reach out to you.
The decrease in the cost of sequencing, the increasing emphasis on early identification and prevention of complex genetic abnormalities, and the increasing maternal age leading to pregnancy problems are projected to fuel the expansion of the carrier screening market.
North America has the greatest market share due to increased healthcare infrastructure, rising per capita income, and improved reimbursement policies in the region.
The major players in the market are Opko Health, Quest Diagnostics Incorporated, Eurofins Scientific, Sema4, Fulgenmt Genetics Inc., Invitae Corporation, Laboratory Corporation of America Holdings, and Illumina Inc.
